Professor Jane Farrar is Director of Undergraduate Teaching and Learning for the School of Genetics and Microbiology, Trinity College Dublin, is on the Board of the Trinity College Institute of Neuroscience (TCIN), is a member of the scientific advisory board of Foundation Fighting Blindness USA and was a Co-Founder, Director and CSO of Genable Technologies, recently acquired by Spark Therapeutics. Professor Farrar has over two decades of experience in the field of inherited eye disorders. Her research interests include elucidation of the genetic etiology and molecular pathogenesis of hereditary neurodegenerative diseases of the retina. Therapeutic avenues being investigated for these ocular conditions include gene and cell-based approaches. Key achievements include the identification some of the first disease genes implicated as causative of inherited retinopathies using genetic linkage analysis, and more recently, characterization of disease causing mutations using NGS-based methodologies and the development of novel technologies for treatment of inherited ocular disorders employing AAV-mediated gene delivery, amongst other approaches. Professor Farrar has been PI or Co-PI on many national and international research awards generating significant research funding. Additionally Professor Farrar is an inventor on a portfolio of granted patents in many jurisdictions together with a number of filed patent applications.